首页 | 本学科首页   官方微博 | 高级检索  
     

2020年美国糖尿病学会(ADA)科学年会精粹解读与热点辩论
引用本文:鲁瑾,张朝云. 2020年美国糖尿病学会(ADA)科学年会精粹解读与热点辩论[J]. 中华内分泌代谢杂志, 2021, 0(3): 180-187
作者姓名:鲁瑾  张朝云
作者单位:海军军医大学第一附属医院;复旦大学附属华山医院内分泌科
摘    要:
第80届美国糖尿病学会(ADA)科学年会于2020年6月12日至16日在线上召开。本次ADA年会针对糖尿病相关并发症的主题进行了热点辩论,内分泌学家和心脏病专家对此提出了不同的观点和见解。本文主要围绕以下5个主题展开的辩论进行了总结:(1)糖尿病微血管和大血管并发症是不同的病理生理存在。(2)2型糖尿病心血管风险和疾病...

关 键 词:2020美国糖尿病学会  糖尿病  血管并发症  心血管疾病  一级预防  二级预防

Essence interpretation and hot debates of American Diabetes Association(ADA)Scientific Sessions in 2020
Lu Jin,Zhang Zhaoyun. Essence interpretation and hot debates of American Diabetes Association(ADA)Scientific Sessions in 2020[J]. Chinese Journal of Endocrinology and Metabolism, 2021, 0(3): 180-187
Authors:Lu Jin  Zhang Zhaoyun
Affiliation:(Department of Endocrine and Metabolic Diseases,Changhai Hospital,the First Affiliated Hospital of Naval Medical University,Shanghai 200433,China;Department of Endocrine and Metabolic Diseases,Huashan Hospital,Shanghai Fudan University School of Medicine,Shanghai 200040,China)
Abstract:
The 80th American Diabetes Association(ADA)Scientific Sessions was held online from June 12 to 16,2020.There was some hot debates on the topics of diabetes related complications in the annual meeting of ADA.Endocrinologists and cardiologists debated and presented different perspectives.This paper will summarize the debates on the following five topics:(1)Microvascular and macrovascular complications of diabetes are distinct pathophysiologic entities.(2)Guideline recommendations for cardiovascular risk and disease management in type 2 diabetes.(3)Drawing the line between primary and secondary prevention—necessary or too simplistic?(4)Should metformin be considered first-line therapy for individuals with type 2 diabetes with established arteriosclerotic cardiovascular disease(ASCVD)or at high risk for ASCVD?(5)Primary cardiovascular prevention with sodium-glucose co-transporter 2(SGLT2)inhibitors or glucagon-like peptide-1(GLP-1)receptor agonists.
Keywords:2020 American Diabetes Association  Diabetes mellitus  Vascular complications  Cardiovascular disease  Primary prevention  Secondary prevention
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号